Trial Profile
Lung Transplantation Using Hepatitis C Positive Donors to Hepatitis C Negative Recipients: A Pilot Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase 0
Latest Information Update: 08 Dec 2023
Price :
$35
*
At a glance
- Drugs Sofosbuvir/velpatasvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- 05 Dec 2023 Planned End Date changed from 17 Apr 2023 to 31 Dec 2024.
- 24 May 2022 Planned End Date changed from 17 Apr 2022 to 17 Apr 2023.
- 27 Sep 2021 Planned End Date changed from 17 Apr 2021 to 17 Apr 2022.